Low Group | High Group | p values | |
---|---|---|---|
No of patients | 13 | 27 | |
Demographic characteristics | |||
Age, years | 66 (55 − 80) | 71 (62 − 84) | 0.29 |
APACHE II Score | 24 (23 − 27) | 24 (17 − 32) | 0.98 |
Comorbidities | |||
Diabetes, n (%) | 7 (53) | 4 (26) | 0.02 |
Cirrhosis, n (%) | 2 (15) | 5 (18) | 0.99 |
Sepsis, n (%) | 11 (84) | 14 (51) | |
Pulmonary infection | 9 (81) | 9 (33) | 0.04 |
Shock, n (%) | 3 (23) | 10 (37) | 0.48 |
Septic | 2 (15) | 7 (26) | |
Hypovolemic | 0 | 2 (7) | |
Cardiogenic | 1 (7) | 1 (4) | |
Invasive Ventilation, n (%) | 7 (54) | 14 (52) | 0.98 |
PEEP, cm H2O | 8 (5 − 9) | 6 (5 − 10) | 0.92 |
Lactate, mmol/L | 2.6 (2.1 − 3.2) | 2.6 (1.8 − 4.5) | 0.75 |
Hemoglobin (mg/dL) | 12.1 (9.6 − 13.3) | 11.3 (9.8 − 13.1) | 0.58 |
Enhanced OER,n (%) | 4 (30) | 6 (22) | 0.71 |
Crystalloids,n (%) | 6 (46) | 12 (44) | 0.73 |
Fluid volume (ml/kg) | 8.27 (6.2 − 12.5) | 8.62 (6.3 − 15.8) | 0.76 |
Fluid rate (ml/min) | 21.3 (16.9 − 32.5) | 19.2 (16.1 − 23.5) | 0.35 |
Baseline metabolic variables | |||
ScvO2, % | 63 (53 − 71) | 70 (61 − 75) | 0.18 |
PvaCO2, mmHg | 4.6 (3.2 − 6.6) | 8.7 (7.3 − 11.5) | < 0.01 |
PvaCO2/CavO2, mmHg/mL | 1.0 (0.8 − 1.1) | 2.1(1.7 − 2.4) | < 0.01 |
Oxygen delivery, mL/min/m2 | 355 (251 − 390) | 442 (305 − 511) | 0.07 |
Oxygen consumption, mL/min/m2 | 101 (89 − 119) | 106 (92 − 160) | 0.22 |
Oxygen extraction, % | 33 (25 − 42) | 28 (25 − 36) | 0.34 |
Baseline hemodynamic variables | |||
Cardiac Index, L/min/m2 | 2.1 (1.7 − 2.4) | 3.1 (1.9 − 3.6) | 0.16 |
Stroke Volume, mL | 44 (39 − 52) | 56 (40 − 68) | 0.22 |
Heart rate, beats/min | 93 (75 − 105) | 95 (79 − 112) | 0.81 |
Pulse Pressure, mmHg | 53 (39 − 68) | 57 (45 − 65) | 0.26 |
Mean Arterial Pressure, mmHg | 77 (69 − 85) | 80 (69 − 87) | 0.64 |
Central Venous Pressure, mmHg | 10 (3 − 11) | 8 (4 − 11) | 0.87 |